Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

leo pharma a/s - betamethasondinatriumphosphat, calcipotriol - kutanskum - 50 mikrog/g+0,5 mg/g

Den Europæiske Union - dansk - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - solriamfetol hydrochlorid - narcolepsy; sleep apnea, obstructive - psychoanaleptics, - sunosi er indiceret til at forbedre vågenhed og reducere overdreven søvnighed i dagtimerne i voksne patienter med narkolepsi (med eller uden katapleksi). sunosi er indiceret til at forbedre vågenhed og reducere overdreven søvnighed i dagtimerne (eds) hos voksne patienter med obstruktiv søvnapnø (osa), hvis eds har ikke været tilfredsstillende, behandlet med primær osa terapi, såsom kontinuerlig positiv luftvejs tryk (cpap).

Den Europæiske Union - dansk - EMA (European Medicines Agency)

bioprojet pharma - pitolisant - narkolepsi - andre narkotika stoffer - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

ucb pharma ltd - natriumoxybat - cataplexy; narcolepsy - andre narkotika stoffer - behandling af narkolepsi med katapleksi hos voksne patienter.

Danmark - dansk - SEGES Landbrug & Fødevarer

cheminova deutschland gmbh & co. kg - quinoclamin - vanddispergerbart pulver - 250 g/kg quinoclamin

Danmark - dansk - SEGES Landbrug & Fødevarer

agroplanta gmbh & co. kg - additiv - flydende middel - 1000 g/l additiv

Den Europæiske Union - dansk - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - linaclotide - irritabelt tarmsyndrom - lægemidler til forstoppelse - constella er indiceret til symptomatisk behandling af moderat til svær irritabel tarmsyndrom med forstoppelse (ibs-c) hos voksne.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

medice arzneimittel pütter gmbh & co. kg - dexamfetaminsulfat - tabletter - 20 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - upadacitinib - arthritis, reumatoid - immunosuppressiva - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

medice arzneimittel pütter gmbh & co. kg - methylphenidathydrochlorid - tabletter - 10 mg